指南与共识胃肠动力与功能性疾病

罗马基金会工作组报告:感染后肠易激综合征

Rome Foundation Working Team Report on Post-Infection Irritable Bowel Syndrome.
指南 / 共识 · Gastroenterology · 2018-11-28

罗马基金会工作组基于文献系统综述与德尔菲共识,总结感染后肠易激综合征(PI-IBS)的临床特征、病理生理及动物模型,指出约10%感染性肠炎患者发生PI-IBS,危险因素包括女性、低龄、急性胃肠炎期间或之前心理困扰及急性发作严重程度,目前无证据支持的有效药物策略,提出基于共识的诊断与治疗流程。

要点

  • 约10%的感染性肠炎患者发生PI-IBS。
  • 危险因素包括女性、低龄、急性胃肠炎期间或之前心理困扰及急性发作严重程度。
  • 无证据支持的有效药物策略,提供基于共识的治疗流程。

核心结论

  • 基于文献系统综述和团队经验,总结PI-IBS的临床特征、病理生理(来自动物模型和人体研究)及进展,提出基于团队共识的诊断和治疗流程,并提出未来研究方向。

研究设计与样本

  • 罗马基金会工作组对文献数据库进行循证综述,描述PI-IBS的临床特征(诊断)、病理生理(肠道感觉运动功能、微生物群、免疫失调、屏障功能障碍、肠内分泌途径和遗传学)及动物模型,采用德尔菲共识系统制定管理指南,并根据已发表发现和团队成员经验制定治疗流程。

主要发现

  • 约10%的感染性肠炎患者发生PI-IBS。
  • 危险因素包括女性、低龄、急性胃肠炎期间或之前心理困扰及急性发作严重程度。
  • PI-IBS的发病机制似乎涉及肠道微生物组改变以及上皮、血清素能和免疫系统因素,但这些机制尚未完全理解。
  • 目前没有循证有效的药物策略用于治疗PI-IBS。

关键数值与推荐

  • 提供基于临床表现和潜在疾病机制的共识治疗流程。

临床怎么用

  • 基于团队共识的诊断和治疗流程可用于PI-IBS的临床管理。

局限性

  • PI-IBS的机制尚未完全理解。
  • 目前没有循证有效的药物策略用于治疗PI-IBS。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND & AIMS: The existence of postinfection irritable bowel syndrome (PI-IBS) has been substantiated by epidemiology studies conducted in diverse geographic and clinical settings. However, the available evidence has not been well summarized, and there is little guidance for diagnosis and treatment of PI-IBS. The ROME Foundation has produced a working team report to summarize the available evidence on the pathophysiology of PI-IBS and provide guidance for diagnosis and treatment, based on findings reported in the literature and clinical experience. METHODS: The working team conducted an evidence-based review of publication databases for articles describing the clinical features (diagnosis), pathophysiology (intestinal sensorimotor function, microbiota, immune dysregulation, barrier dysfunction, enteroendocrine pathways, and genetics), and animal models of PI-IBS. We used a Delphi-based consensus system to create guidelines for management of PI-IBS and a developed treatment algorithm based on published findings and experiences of team members. RESULTS: PI-IBS develops in about 10% of patients with infectious enteritis. Risk factors include female sex, younger age, psychological distress during or before acute gastroenteritis, and severity of the acute episode. The pathogenesis of PI-PBS appears to involve changes in the intestinal microbiome as well as epithelial, serotonergic, and immune system factors. However, these mechanisms are incompletely understood. There are no evidence-based, effective pharmacologic strategies for treatment of PI-IBS. We provide a consensus-based treatment algorithm, based on clinical presentation and potential disease mechanisms. CONCLUSIONS: Based on a systematic review of the literature and team experience, we summarize the clinical features, pathophysiology (from animal models and human studies), and progression of PI-IBS. Based on these findings, we present an algorithm for diagnosis and treatment of PI-IBS based on team consensus. We also propose areas for future investigation.

来源:Gastroenterology,查看原文。版权归原作者所有。

引用

  1. Barbara G, Grover M, Bercik P, et al. Rome Foundation Working Team Report on Post-Infection Irritable Bowel Syndrome. Gastroenterology. 2018. PMID: 30009817. doi:10.1053/j.gastro.2018.07.011

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。